Involving a collaboration with 118 investigators contributing from 89 institutions, scientists from the and Berlin Institute of Health at Charité (BIH) and the Precision Healthcare University Research Institute (Queen Mary University of London) have led the world’s largest study on the genetic regulation of >1,000 blood proteins which holds the potential to transform our understanding of different diseases and their treatment opportunities.